Mitochondrial inflexibility ignites tumor immunogenicity in postoperative glioblastoma

Nat Commun. 2025 Jul 28;16(1):6946. doi: 10.1038/s41467-025-62244-5.

Abstract

Cellular and molecular heterogeneity contributes to the insufficient immunogenicity of glioblastoma multiforme (GBM), a lethal malignancy characterized by post-resection relapse, ultimately leading to limited immune cell infiltration. Here, we report a strategy to boost tumor immunity by activating the endogenous cGAS-STING signaling pathway through in-situ manipulation of the mitochondrial electron transport chain (ETC), thereby augmenting the immune responsiveness of GBM. Under white light irradiation, the synthetic butterfly-shaped photosensitizer B-TTPy disrupts the mitochondrial ETC by producing excessive reactive oxygen species. Synergistically, inhibition of checkpoint kinase 1 amplifies ETC dysfunction, thus enhancing the cytotoxicity of B-TTPy against tumor cells. Our results demonstrate that the in-house-customized Mitochondrial Electron Alteration Nanoparticles in Glioblastoma (MEANING) efficiently activate innate and adaptive immune response by recruiting antigen-presenting cells and cytotoxic T cells to the surgical margin. Moreover, biodegradable hydrogel-medicated surgical cavity treatment with MEANING can reshape the immunosuppressive tumor microenvironment and eliminate residual GBM cells. In sum, our findings establish a local immune activation approach for GBM, to prevent postoperative tumor recurrence and identify ETC blockade as a promising therapeutic strategy for low-immunogenic tumors.

MeSH terms

  • Adaptive Immunity / drug effects
  • Animals
  • Brain Neoplasms* / immunology
  • Brain Neoplasms* / surgery
  • Cell Line, Tumor
  • Female
  • Glioblastoma* / immunology
  • Glioblastoma* / pathology
  • Glioblastoma* / surgery
  • Glioblastoma* / therapy
  • Humans
  • Mice
  • Mitochondria* / drug effects
  • Mitochondria* / immunology
  • Mitochondria* / metabolism
  • Nanoparticles / chemistry
  • Neoplasm Recurrence, Local / immunology
  • Neoplasm Recurrence, Local / prevention & control
  • Photosensitizing Agents / pharmacology
  • Reactive Oxygen Species / metabolism
  • Signal Transduction / drug effects
  • T-Lymphocytes, Cytotoxic / drug effects
  • T-Lymphocytes, Cytotoxic / immunology
  • Tumor Microenvironment / drug effects
  • Tumor Microenvironment / immunology

Substances

  • Reactive Oxygen Species
  • Photosensitizing Agents